This current study aims to examine KRT8 expression levels in lung adenocarcinoma patients undergoing immunotherapy, thereby providing a valuable tool for stratifying patients at heightened risk of developing IRP. The gene discussed is KRT8; the disease is lung adenocarcinoma.